Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)
Giuseppe Argenziano(Regione Campania), C. Flohr(King's College London), Francesco Tonon(University of Brescia), Giampiero Girolomoni(University of Verona), Andrea Chiricozzi(Università Cattolica del Sacro Cuore), Krisztián Gáspár(University of Debrecen), Mariateresa Rossi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), B.W.M. Arents(European Federation of Allergy and Airways Diseases Patients Associations), Corinna Dressler(Charité - Universitätsmedizin Berlin), Nicole Fosse(University Hospital of Basel), Thomas Bieber(CK-CARE), Stamatios Gregoriou(Andreas Sygros Hospital), Francesco Cusano(Azienda Ospedaliera G.Rummo), Mette Deleuran(Aarhus University Hospital), G. Avila Valle(Humboldt-Universität zu Berlin), Uwe Gieler(Universitätsklinikum Gießen und Marburg), Luca Stingeni(University of Perugia), Paolo D. Pigatto(University of Milan), Alexander Nast(Humboldt-Universität zu Berlin), Antonio Torrelo(Hospital Infantil Universitario Niño Jesús), S. Barbarot(Hotel Dieu Hospital), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), E. Serra‐Baldrich(Universitat Autònoma de Barcelona), Paolo Amerio(Sunnybrook Health Science Centre), Maria Kinberger(Humboldt-Universität zu Berlin), Piergiacomo Calzavara‐Pinton(University of Brescia), Charlotte G. Mørtz(University of Southern Denmark), Uffe Nygaard(Aarhus University Hospital), Pietro Quaglino(Department of Medical Sciences), Cataldo Patruno(Magna Graecia University), Dagmar Simon(University of Bern), Andreas Wollenberg(University Hospital Augsburg), Helen A. Brough(Guy's and St Thomas' NHS Foundation Trust), Jacek C. Szepietowski(Wroclaw Medical University), Luigi Naldi(Centro Studi GISED), M. Redding(National One Call (United Kingdom)), Paolo Gisondi(University of Verona), Martin Dittmann(Humboldt-Universität zu Berlin), Thomas WERFEL(King's College London), Monica Corazza(University of Ferrara), J Ring(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Stéphanie Christen-Zäch(University of Lausanne), Zsuzsanna Z. SZALA I st, Salvatore AMATO(University of Palermo), Eva Maria Rehbinder(Oslo University Hospital), Antjie H. FINK-WAGNER(University Hospital of Basel), N. Aszodi(LMU Klinikum)
Cited by 3
Related Papers
The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k